InvestSMART

Nova Eye Medical Limited (ASX: EYE) - Announcements

- Current share price for EYE : $0.135

ASX company news and announcements for Nova Eye Medical Limited (EYE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nova Eye Medical Limited (EYE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nova Eye Medical Limited (EYE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nova Eye Medical Limited (EYE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Notification regarding unquoted securities - EYE 30 Nov 2021 2:58PM $0.320 $0.135 fallen by 57.81%
$38 Cancel - Proposed issue of securities - EYE 30 Nov 2021 2:37PM $0.320 $0.135 fallen by 57.81%
$38 Notification regarding unquoted securities - EYE 30 Nov 2021 12:06PM $0.320 $0.135 fallen by 57.81%
$38 Appendix 3Z Mr A Sundich 24 Nov 2021 5:48PM $0.370 $0.135 fallen by 63.51%
$38 AGM voting results 24 Nov 2021 4:52PM $0.370 $0.135 fallen by 63.51%
$38 EYE AGM Presentation 24 Nov 2021 1:19PM $0.395 $0.135 fallen by 65.82%
$38 AGM Withdrawal of AGM resolutions 24 Nov 2021 11:33AM $0.370 $0.135 fallen by 63.51%
$38 Resignation of Director 24 Nov 2021 11:28AM $0.385 $0.135 fallen by 64.94%
$38 Job Keeper Notice 11 Nov 2021 11:01AM $0.400 $0.135 fallen by 66.25%
$38 Update - Proposed issue of securities - EYE 4 Nov 2021 4:01PM $0.405 $0.135 fallen by 66.67%
$38 US Government Stimulus Loan Forgiven 26 Oct 2021 10:27AM $0.420 $0.135 fallen by 67.86%
$38 Notice of Annual General Meeting/Proxy Form 21 Oct 2021 2:14PM $0.410 $0.135 fallen by 67.07%
$38 5 Year Efficacy of iTrack to be Spotlighted at ESCRS 7 Oct 2021 11:58AM $0.400 $0.135 fallen by 66.25%
$38 Date of AGM and Closing Date for Director Nominations 30 Sep 2021 10:52AM $0.405 $0.135 fallen by 66.67%
$38 Nova Eye to Present at ASX Small to Mid-Cap Conference 10 Sep 2021 8:31AM $0.370 $0.135 fallen by 63.51%
$38 Closure of Share Facility Unmarketable Parcels 3 Sep 2021 9:02AM $0.450 $0.135 fallen by 70%
$38 Application for quotation of securities - EYE 27 Aug 2021 9:13AM $0.425 $0.135 fallen by 68.24%
$38 Proposed issue of securities - EYE 26 Aug 2021 9:58AM $0.430 $0.135 fallen by 68.60%
$38 Aquisition of Glaucoma Patents 26 Aug 2021 9:52AM $0.430 $0.135 fallen by 68.60%
$38 Appendix 4G and Corporate Governance Statement 19 Aug 2021 8:13AM $0.430 $0.135 fallen by 68.60%
$38 FY21 Investor presentation 19 Aug 2021 8:12AM $0.430 $0.135 fallen by 68.60%
$38 Full Year Results FY21 19 Aug 2021 8:12AM $0.430 $0.135 fallen by 68.60%
$38 FY21 Appendix 4E and Annual Report 19 Aug 2021 8:12AM $0.430 $0.135 fallen by 68.60%
$38 Application for quotation of securities - EYE 18 Aug 2021 3:11PM $0.445 $0.135 fallen by 69.66%
$38 Proposed issue of securities - EYE 18 Aug 2021 3:07PM $0.445 $0.135 fallen by 69.66%

226 - 250 of 357 results

Page 10 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.